ClinicalTrials.Veeva

Menu
G

Global Clinical Trials | Pretoria, South Africa

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

S-217622
PTC299
Obeldesivir
Ritonavir
Naproxen
Peramivir
GRT7039
PF-07321332
BLU-5937
Ranolazine

Parent organization

This site is a part of Global Clinical Trials

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 15 total trials

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-1)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Enrolling
Refractory Chronic Cough
Drug: BLU-5937
Drug: Placebo

An open-label, single-arm clinical trial to confirm the safety of monoarticular injections or bi-lateral intra-articular injections of RTX-GRT7039 in...

Active, not recruiting
Osteoarthritis
Drug: RTX-GRT7039

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Enrolling
Lower Respiratory Tract Illness
Biological: RSVpreF
Biological: Placebo

Trial sponsors

Pfizer logo
Gilead Sciences logo
A
B
BioCryst logo
BioNTech logo
G
PTC Therapeutics logo
Regeneron Pharmaceuticals logo
Shionogi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems